ORCID: https://orcid.org/0000-0002-0749-1389
(2024):
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network.
In: Lancet, Vol. 403, No. 10441: pp. 2293-2306
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Institute for Medical Information Processing, Biometry and Epidemiology Medicine > Medical Center of the University of Munich > Medical Clinic and Outpatient Clinic III (Oncology) |
| Subjects: | 600 Technology > 610 Medicine and health |
| ISSN: | 0140-6736 |
| Annotation: | Online first |
| Language: | English |
| Item ID: | 116663 |
| Date Deposited: | 21. May 2024 06:24 |
| Last Modified: | 05. Sep 2024 12:15 |
Actions (login required)
- View Item
